Synthetic Curcuminoid Induces Cell Death in Trypanosoma cruzi Through Oxidative Stress and Exhibits Synergistic Activity with Benznidazole

BACKGROUND: Benznidazole is currently one of the few drugs available for the treatment of Chagas disease; however, it is associated with significant limitations, including adverse drug reactions and reduced or absent efficacy during the chronic phase. Given the inadequacy of existing therapies, this study investigates the potential therapeutic effect of the synthetic curcuminoid derivative (1E,4E)- 1,5-bis(4-methoxyphenyl)penta-1,4-dien-3-one (DBOCH3) against T. cruzi Y strain using both in vitro and in silico approaches. RESULTS: In vitro cytotoxicity assays demonstrated that treatment of LLC-MK2 cells with DBOCH3 resulted in a selectivity index of 36, which is 15 times higher than that of benznidazole. Furthermore, DBOCH3 exhibited inhibitory activity against the main life forms of T. cruzi: epimastigotes, trypomastigotes, and amastigotes. Checkerboard matrix assays based on the Bliss independence model revealed that the combination of DBOCH3 and benznidazole exerted a potent synergistic effect against both epimastigote and trypomastigotes forms, particularly within specific concentration combinations, without induced significant toxicity in LLC-MK2 host cells. Flow cytometry analysis indicated that DBOCH3 was associated with parasite cell-death events indicated by 7-AAD and Annexin V-PE labeling, accompanied by cytoplasmic ROS accumulation and loss of mitochondrial transmembrane potential. In silico molecular docking studies revealed that DBOCH3 was predicted to interact with selected T. cruzi enzymes, with predicted binding poses in TcGAPDH and trypanothione reductase (TcTR), with more favorable (more negative) ΔG values than benznidazole. CONCLUSION​: These findings indicate that DBOCH3 appears to possess promising characteristics, suggesting that its synergistic potential with benznidazole might offer a viable strategy to enhance antichagasic efficacy and mitigate drug-associated toxicity.

Authors

Institutions

Publication Details

Journal
Acta Parasitologica
Published
2026-11-13
DOI
https://doi.org/10.1007/s11686-026-01443-6
Primary Topic
Trypanosoma species research and implications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Synthetic Curcuminoid Induces Cell Death in Trypanosoma cruzi Through Oxidative Stress and Exhibits Synergistic Activity with Benznidazole

Emanuel Paula Magalhães, Arif Ali, Beatriz Maria Silva Martins, Hélcio Silva dos Santos et al.
1 links
Acta Parasitologica
Trypanosoma species research and implications
article

Synthetic Curcuminoid Induces Cell Death in Trypanosoma cruzi Through Oxidative Stress and Exhibits Synergistic Activity with Benznidazole

Emanuel Paula Magalhães, Arif Ali, Beatriz Maria Silva Martins, Hélcio Silva dos Santos, Ramon Róseo Paula Pessoa Bezerra de Menezes, John Washington Cavalcante, Lyanna Rodrigues Ribeiro, Emmanuel Silva Marinho, Naiara Dutra Barroso Gomes, Márcia Machado Marinho, Marcelo Morais Gomes Maia, Alice Maria Costa Martins, Felipe Ramon Cunha da Silva, Mateus Edson da Silva
article en

Abstract

BACKGROUND: Benznidazole is currently one of the few drugs available for the treatment of Chagas disease; however, it is associated with significant limitations, including adverse drug reactions and reduced or absent efficacy during the chronic phase. Given the inadequacy of existing therapies, this study investigates the potential therapeutic effect of the synthetic curcuminoid derivative (1E,4E)- 1,5-bis(4-methoxyphenyl)penta-1,4-dien-3-one (DBOCH3) against T. cruzi Y strain using both in vitro and in silico approaches. RESULTS: In vitro cytotoxicity assays demonstrated that treatment of LLC-MK2 cells with DBOCH3 resulted in a selectivity index of 36, which is 15 times higher than that of benznidazole. Furthermore, DBOCH3 exhibited inhibitory activity against the main life forms of T. cruzi: epimastigotes, trypomastigotes, and amastigotes. Checkerboard matrix assays based on the Bliss independence model revealed that the combination of DBOCH3 and benznidazole exerted a potent synergistic effect against both epimastigote and trypomastigotes forms, particularly within specific concentration combinations, without induced significant toxicity in LLC-MK2 host cells. Flow cytometry analysis indicated that DBOCH3 was associated with parasite cell-death events indicated by 7-AAD and Annexin V-PE labeling, accompanied by cytoplasmic ROS accumulation and loss of mitochondrial transmembrane potential. In silico molecular docking studies revealed that DBOCH3 was predicted to interact with selected T. cruzi enzymes, with predicted binding poses in TcGAPDH and trypanothione reductase (TcTR), with more favorable (more negative) ΔG values than benznidazole. CONCLUSION​: These findings indicate that DBOCH3 appears to possess promising characteristics, suggesting that its synergistic potential with benznidazole might offer a viable strategy to enhance antichagasic efficacy and mitigate drug-associated toxicity.

Acta ParasitologicaVol. 71(6)
Universidade Estadual do Ceará (BR), Universidade Federal do Ceará (BR), State University of Vale do Acaraú (BR)
Good health and well-being
Trypanosoma species research and implications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon